Aviator80 schreef op 12 november 2020 14:31:
[...]
This is interesting, although Acacia doesn't have an European sales force (yet):
Commercialization plans: PAION continues to conduct pre-commercialization activities. The build-up of its own distribution structure in Europe is dependent on PAION’s ability to add more products to its commercial portfolio. Thus, PAION is also considering out-licensing remimazolam for commercialization in Europe alternatively.